NextRNA Therapeutics, Inc.
NextRNA Therapeutics is a biotechnology company focused on developing transformative small molecule therapeutics targeting long non-coding RNAs (lncRNAs), with a primary focus on oncology and neuroscience. They aim to inhibit the function of pathological lncRNAs by disrupting their interaction with RNA-binding proteins (RBPs) using small molecules. The company emphasizes pioneering science, strategic partnerships, and a mission to impact patients with innovative medicines.
Industries
Nr. of Employees
small (1-50)
NextRNA Therapeutics, Inc.
Cambridge, Massachusetts, United States, North America
Products
lncRNA-targeting small molecule oncology programs
Small molecule development programs aimed at inhibiting pathological lncRNA function by disrupting lncRNA–RBP interactions; programs include early preclinical candidates and targets identified by the company's platform.
lncRNA-targeting small molecule oncology programs
Small molecule development programs aimed at inhibiting pathological lncRNA function by disrupting lncRNA–RBP interactions; programs include early preclinical candidates and targets identified by the company's platform.
Services
Collaborative drug discovery and co-development partnerships
Joint development and licensing collaborations with pharmaceutical partners to advance lncRNA-targeting small molecule programs from discovery through preclinical development and beyond.
Collaborative drug discovery and co-development partnerships
Joint development and licensing collaborations with pharmaceutical partners to advance lncRNA-targeting small molecule programs from discovery through preclinical development and beyond.
Expertise Areas
- lncRNA-targeted small molecule discovery
- RNA–protein interaction biology
- Computational target mapping and prioritization
- Preclinical small molecule development
Key Technologies
- Computational target-mapping engines for RNA targets
- lncRNA–RBP interaction assays
- Biochemical and biophysical target engagement assays
- Small molecule screening and medicinal chemistry